HYDROXYLATION AND FORMATION OF ELECTROPHILIC METABOLITES OF TIENILIC ACID AND ITS ISOMER BY HUMAN LIVER-MICROSOMES - CATALYSIS BY A CYTOCHROME-P450 IIC DIFFERENT FROM THAT RESPONSIBLE FOR MEPHENYTOIN HYDROXYLATION

被引:65
作者
DANSETTE, PM
AMAR, C
VALADON, P
PONS, C
BEAUNE, PH
MANSUY, D
机构
[1] UNIV PARIS 05,CHIM & BIOCHIM PHARMACOL & TOXICOL LAB,CNRS,URA 400,F-75270 PARIS 06,FRANCE
[2] FAC MED NECKER ENFANTS MALAD,BIOCHIM PHARMACOL & METAB LAB,INSERM,U75,F-75730 PARIS 15,FRANCE
关键词
D O I
10.1016/0006-2952(91)90627-H
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tienilic acid (TA) is metabolized by human liver microsomes in the presence of NADPH with the major formation of 5-hydroxytienilic acid (5-OHTA) which is derived from the hydroxylation of the thiophene ring of TA. Besides this hydroxylation, TA is oxidized into reactive metabolites which covalently bind to microsomal proteins. Oxidation of an isomer of tienilic acid (TAI), bearing the aroyl substituent on position 3 (instead of 2) of the thiophene ring, by human liver microsomes, gives a much higher level of covalent binding to proteins. Both covalent binding of TA and TAI metabolites are almost completely suppressed in the presence of glutathione. These three activities of human liver microsomes (TA 5-hydroxylation, covalent binding of TA and TAI metabolites) seem dependent on the same cytochrome P450 of the IIC subfamily, since (i) antibodies against human liver cytochromes P450 IIC strongly inhibit these three activities, (ii) there is a clear correlation between these activities in various human liver microsomes, and (iii) TA acts as a competitive inhibitor for TAI activation into electrophilic metabolites (K(i) approximately-equal 25-mu-M) and TAI inhibits TA 5-hydroxylation. However cross inhibition experiments indicate that tienilic acid hydroxylation and mephenytoin hydroxylation, a typical reaction of some human liver P450 IIC isoenzymes, are not catalysed by the same member of the P450 IIC subfamily.
引用
收藏
页码:553 / 560
页数:8
相关论文
共 20 条
[1]   HUMAN ANTI-ENDOPLASMIC RETICULUM AUTOANTIBODIES APPEARING IN A DRUG-INDUCED HEPATITIS ARE DIRECTED AGAINST A HUMAN-LIVER CYTOCHROME-P-450 THAT HYDROXYLATES THE DRUG [J].
BEAUNE, P ;
DANSETTE, PM ;
MANSUY, D ;
KIFFEL, L ;
FINCK, M ;
AMAR, C ;
LEROUX, JP ;
HOMBERG, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (02) :551-555
[2]  
BRAY H G, 1971, Xenobiotica, V1, P157
[3]   OXIDATIVE ACTIVATION OF THE THIOPHENE RING BY HEPATIC-ENZYMES - HYDROXYLATION AND FORMATION OF ELECTROPHILIC METABOLITES DURING METABOLISM OF TIENILIC ACID AND ITS ISOMER BY RAT-LIVER MICROSOMES [J].
DANSETTE, PM ;
AMAR, C ;
SMITH, C ;
PONS, C ;
MANSUY, D .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (05) :911-918
[4]  
FENSELAU A, 1970, J BIOL CHEM, V245, P1239
[5]   MEPHENYTOIN-TYPE POLYMORPHISM OF DRUG OXIDATION - PURIFICATION AND CHARACTERIZATION OF A HUMAN-LIVER CYTOCHROME-P-450 ISOZYME CATALYZING MICROSOMAL MEPHENYTOIN HYDROXYLATION [J].
GUT, J ;
MEIER, UT ;
CATIN, T ;
MEYER, UA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 884 (03) :435-447
[6]   SYNTHESIS OF C-14-LABELED DIURETIC - 2,3-DICHLORO-4-(2-THENOYL)-PHENOXYACETIC ACID, C-14-LABELED IN THENOYL CARBONYL GROUP (DCI TIENILIC ACID) [J].
HERBERT, M ;
PICHAT, L .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1976, 12 (03) :437-441
[7]  
HOMBERG JC, 1984, CLIN EXP IMMUNOL, V55, P561
[8]   METABOLISM OF TENOXICAM IN RATS [J].
ICHIHARA, S ;
TSUYUKI, Y ;
TOMISAWA, H ;
FUKAZAWA, H ;
NAKAYAMA, N ;
TATEISHI, M ;
JOLY, R .
XENOBIOTICA, 1984, 14 (09) :727-739
[9]   CYTOCHROME-P-450 MONO-OXYGENASE ACTIVITIES IN HUMAN AND RAT-LIVER MICROSOMES [J].
KREMERS, P ;
BEAUNE, P ;
CRESTEIL, T ;
DEGRAEVE, J ;
COLUMELLI, S ;
LEROUX, JP ;
GIELEN, JE .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1981, 118 (03) :599-606
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265